Literature DB >> 9453657

Expression and purification of the recombinant lethal factor of Bacillus anthracis.

P Gupta1, S Batra, A P Chopra, Y Singh, R Bhatnagar.   

Abstract

The structural gene for the 90-kDa lethal factor (LF) isolated from Bacillus anthracis was expressed as a fusion protein with six histidine residues in Escherichia coli. Expression of LF in E. coli under the transcriptional regulation of the T5 promoter yielded a soluble cytosolic protein with an apparent molecular mass of 90 kDa, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Recombinant LF reacted with anti-LF antibodies. The protein was purified to homogeneity by nickel nitrilotriacetic acid affinity chromatography and gel filtration on a Sephacryl S-200 column followed by anion exchange on a fast-performance liquid chromatograph with a Resource-Q column. The yield of purified LF from this procedure was 1.5 mg/liter. In solution, trypsin cleaved protective antigen bound to native and recombinant LF with comparable affinities. In macrophage lysis assays, native and recombinant LF exhibited identical potencies. The results suggest that large amounts of biologically active LF can be purified by this procedure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9453657      PMCID: PMC107985     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Expression and purification of anthrax toxin protective antigen from Escherichia coli.

Authors:  M Sharma; P K Swain; A P Chopra; V K Chaudhary; Y Singh
Journal:  Protein Expr Purif       Date:  1996-02       Impact factor: 1.650

2.  Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells.

Authors:  N Arora; S H Leppla
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

3.  The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor.

Authors:  Y Singh; K R Klimpel; N Arora; M Sharma; S H Leppla
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

4.  Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis.

Authors:  C P Quinn; Y Singh; K R Klimpel; S H Leppla
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

5.  Anthrax protective antigen forms oligomers during intoxication of mammalian cells.

Authors:  J C Milne; D Furlong; P C Hanna; J S Wall; R J Collier
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

6.  Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity.

Authors:  K R Klimpel; N Arora; S H Leppla
Journal:  Mol Microbiol       Date:  1994-09       Impact factor: 3.501

7.  Characterization of macrophage sensitivity and resistance to anthrax lethal toxin.

Authors:  A M Friedlander; R Bhatnagar; S H Leppla; L Johnson; Y Singh
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

8.  Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin.

Authors:  K R Klimpel; S S Molloy; G Thomas; S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

9.  Protein synthesis is required for expression of anthrax lethal toxin cytotoxicity.

Authors:  R Bhatnagar; A M Friedlander
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

10.  Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides.

Authors:  N Arora; S H Leppla
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.486

View more
  5 in total

1.  Identification of amino acid residues of anthrax protective antigen involved in binding with lethal factor.

Authors:  Vibha Chauhan; Rakesh Bhatnagar
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Purification of anthrax edema factor from Escherichia coli and identification of residues required for binding to anthrax protective antigen.

Authors:  P Kumar; N Ahuja; R Bhatnagar
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

3.  Molecular and Genomic Characterization of PFAB2: A Non-virulent Bacillus anthracis Strain Isolated from an Indian Hot Spring.

Authors:  Aparna Banerjee; Vikas K Somani; Priyanka Chakraborty; Rakesh Bhatnagar; Rajeev K Varshney; Alex Echeverría-Vega; Sara Cuadros-Orellana; Rajib Bandopadhyay
Journal:  Curr Genomics       Date:  2019-11       Impact factor: 2.236

4.  Role of the N-terminal amino acid of Bacillus anthracis lethal factor in lethal toxin cytotoxicity and its effect on the lethal toxin neutralization assay.

Authors:  Anita Verma; Leslie Wagner; Scott Stibitz; Nga Nguyen; Flor Guerengomba; Drusilla L Burns
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

5.  Role of N-terminal amino acids in the potency of anthrax lethal factor.

Authors:  Pradeep K Gupta; Mahtab Moayeri; Devorah Crown; Rasem J Fattah; Stephen H Leppla
Journal:  PLoS One       Date:  2008-09-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.